Motif-2-12.7B-Reasoning is positioned as competitive with much larger models, but its real value lies in the transparency of ...
Motif Neurotech, a brain-computer interface (BCI) company developing technologies for mental health, today announced that its ...
Motif Neurotech said its patient registry is now live, accepting submissions from individuals with treatment-resistant ...
- This demonstration of a miniature implantable stimulator used in humans could unlock minimally invasive therapies for treatment-resistant neuropsychiatric disorders - Approximately 30% of adults ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback